National and Kapodistrian University of Athens
Μέτρηση απόλυτου αριθμού βιωσιμότητας στον χρόνο και πιθανών παραγόντων ανάπτυξης σε cd34+ βλαστικά κύτταρα ομφαλοπλακουντιακού αίματος σε κυτταρομετρία ροής
Abstract
dc:descriptionThe isolation of stem cells offers the promise of a remarkable series of new therapeutic methods. Biologic therapies derived from such cells (through regeneration and tissue repair as well as through targeted delivery of genetic material), is expected to be effective in treating a wide range of medical conditions.Diseases such as cancer (the first transplantation of autologous stem cells of the blood has been reported from an American group, in a 3rd year old girl and after 3 years of follow up was found to be healthy and without any indication of disease, (Pediatrics: volume 119, number 1, January 2007), and birth defects are the result of abnormal cell division and differentiation. Understanding these mechanisms will lead us to develop new therapies.In conclusion, cryopreservation and processing UCB units, through the measurement of the absolute numbers of CD34+ cells and their viability, was found to remain stable during the different time periods (24h, 3months, 6months & 1year). The measurement of viability and the absolute numbers of CD34+ cells give us the opportunity for evaluation and control in the processing of umbilical cord stem cells units.Our effort to expand the UCB units and the cells from the umbilical cord opening new areas of research and applications in the field of regenerative medicine.Stem cells are a great promise for use in regenerative medicine and cell therapy in the future.Based on current data, the chances of someone using stem cells throughout life is 1/200, (www.eae.gr), and according to a study in the US one in three chronically ill patients over 65 years old (128 million) will need cell therapy in the coming years. (Nietfeld JJ. Lifetime probabilities of hematopoietic stem cell transplantation in the US Biol. Blood Marrow Transplant. 2008, 14: 316-322).The umbilical cord blood and bone marrow have been proposed as a remedy particularly for blood diseases, malignant and non-malignant tumors of childhood, immune diseases, such as multiple sclerosis and juvenile rheumatoid arthritis. Also, the umbilical cord blood of the children themselves is currently used in clinical trials for the treatment of cerebral palsy and juvenile diabetes, (Duke University Hospital, Dr. Joanne Kurtzberg).The results of these studies are encouraging, but still early, and may help children who have their cryopreservation stem cells stored at birth.Our aim was to evaluate the collection of cord blood while maintaining sufficient progenitor cells to allow for transplantation as well as reduce the risk of microbial contamination during processing.Optimum performance of mononuclear cells remains the most important aspect of cord blood collection. The amount of fetal blood remaining in the placenta and umbilical cord is dependent on a plurality of different factors. The technique of cord blood collection varies between different banks storage and processing, for our study the UCB units collected ectopic.The collection of the placenta is easy and does not disturb the natural course of birth or the postpartum period. In our study we described a simple and effective system for the processing of cord blood in a triple bag collection, which removes 8% of RCB cells and allows the storage of cord blood units in small volumes, units cryopreserved in a final average volume 25ml.In conclusion, the mean absolute number of CD34 + cells was found to be 3,00x106 (n = 4.000), when the threshold value for a transplant is 1.00x105 cells per kilogram body weight.Also, the average viability value was at 90% (n = 4.000), which indicates good techniques followed by cryopreservation and storage of samples. Viability of UBC grafts was tested with trypan blue (n = 4000), and found to be 92% on average. Our results may serve as a control and quality indicators for our method.The presence of erythroblasts in large UCB volumes affects the measurements of WBC cells on a hematology analyzer, but our hypothesis was not observed in our study. We also observed that the low measurements on WBC cells will give us a low number of CD34 + cells in the sample. We also observed a strong correlation between small samples volumes of WBC cells and absolute number of CD34 + cells.To explore possible microbial contamination during processing, we investigated UCB units in a three years period (2008-2010) in absolute numbers, cell viability and infection control, viral serology.In our study we have achieved an increase in the overall yield of nucleated cells after ex vivo expansion using the same combination of cytokines used in the Ueda et al group, except IL-6R.Also, we made a further attempt to culture cells isolated from umbilical cord blood and incubated with fetal cell markers such as Nanog and Oct. Cord blood is an established source for stem cell transplantation procedures. The CD34 + cord blood cells have higher proliferative potential and a higher incidence of long-term repopulating cells in SCID cells.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kalodimou, Vasiliki
- Καλοδήμου, Βασιλική
Subjects
dc:subject × 10Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41971